This content is from: Home

Supreme Court’s Caraco ruling signals need for FDA fix

The US Supreme Court has once again reversed the Federal Circuit in a case some hope may result in the Food and Drug Administration clarifying its guidelines on use codes filed with new drug applications

To access our in-house intelligence please request a trial here.

Read this article – and more – for a one-week period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | One Week Trial